Artificial Intelligence
Rising at a CAGR of 8%, Worldwide Sales of Antineoplastic Agents to Reach a Valuation Of US$ 286.49 billion: Fact.MR Analysis
Rockville, Dec. 20, 2022 (GLOBE NEWSWIRE) — As per this detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, the global antineoplastic agents market is valued at US$ 126.71 billion in 2023 and is predicted to expand at a CAGR of 8.5% from 2023 to 2033.
Antineoplastic agents or drugs are medications used to treat cancer. Anticancer, chemotherapy, and cytotoxic are alternate names for antineoplastic medications. These medications can be found in liquid or pill form. As cancer is becoming a common disorder around the globe, people are being more aware of the disease and available treatments.
Throughout the forecast period, the growth of the global market is anticipated to be aided by the expansion of the healthcare infrastructure across the world. Exorbitant drug costs and stringent product approval regulations are some of the factors hindering the development of anti-neoplastic therapies.
Download Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8071
Biological agents are gaining traction since the outbreak of COVID-19 and high developments are seen in the biological treatment of cancer disorders. To deliver advanced treatment to target patients, various medical researchers are concentrating on nanotechnology. The immune system of the patient is used in biological therapy to treat cancer while protecting healthy cells.
North America and Europe are dominating regional markets for antineoplastic agent producers due to the rising cases of cancers and growing medical tourism. While the Asia Pacific antineoplastic agents market is expected to increase at the fastest pace during the forecast period due to the rapidly developing healthcare industry, key market players are planting their manufacturing units in the region to earn more income.
Key Takeaways from Market Study
- The global market for antineoplastic agents is projected to reach US$ 286.49 billion by 2033.
- Germany’s market is predicted to expand at a CAGR of 6% during the forecast period.
- Demand for antineoplastic agents in China is expected to rise at an impressive CAGR of 12% during the forecast period.
- The demand for biological agents is predicted to rise at a high CAGR of 9% from 2023 to 2033.
Customization on This Report Is Available
(Save 40% on Country & Region Specific Reports):
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8071
Winning Strategy
Key manufacturers of antineoplastic agents are fully focused on developing advanced drugs, for which they are highly investing in R&D activities. This will not only help them to gain more revenue but also to reach dominating market position. Other strategies such as acquisitions, mergers and collaborations are adopted by manufacturers of antineoplastic agents.
- The acquisition of Tidal Therapeutics, a pre-clinical biotech firm in charge of creating an mRNA-based research platform, by Sanofi was announced in April 2021. With the aid of this acquisition, Sanofi will be able to increase the scope of its research in the fields of oncology, immunology, and other diseases.
Key companies in Antineoplastic Agents Market
- AbbVie
- Abraxis
- AstraZeneca
- Baekdu Mountain Pharmaceutical
- Baida Pharmaceutical
- Bayer
- Biogen Idec
- BMS
- Celgene
- CTTQ
- Eisai
Key Segments of Antineoplastic Agents Industry Research
- By Product :
- Chemotherapeutic Agents
- Biological/Immunotherapeutic Agents
- Personalized Medicines
- Alkylating and Alkylating-like Agents
- Hormonal Agents, Miscellaneous Agents
- By End User :
- Hospitals
- Clinics
- Cancer Rehabilitation Centers
- Ambulatory Surgical Centers
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Full Access of this Report Is Available
(Via Secured PayPal Payment Gateway)
https://www.factmr.com/checkout/8071
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global antineoplastic agents market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.
The study divulges essential insights on the market on the basis of product (chemotherapeutic agents, biological/immunotherapeutic agents, personalized medicines, alkylating & alkylating-like agents, hormonal agents, miscellaneous agents) and end user (hospitals, clinics, cancer rehabilitation centers, ambulatory surgical centers), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product modifications /Innovation/p>
4. Key Success Factors
4.1. Strategic Developments
4.2. Key regulations
4.3. Product USPs /Technology
4.4. List of Manufacturers and Providers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Increasing R&D Expenditure
TOC Contd…..
Check out more related studies published by Fact.MR Research:
Viscoelastic Agents Market: Viscoelastic agents are also known as ophthalmic viscosurgical devices which are used to create and maintain space in the anterior chamber of the eye. Viscoelastic agents are required during implantation of an intraocular lens to protect the corneal epithelium. The viscoelastic agents are transparent gel-like substances that have elastic and viscous properties.
Chloride Reagents Kits Market: The human body comprises of several different kind of charged ions in order to provide energy and movement of signals throughout the body. Chloride is one of the most important essential electrolytes present in the body, with an abundance of above 60% of the entire negatively charged ions content. It is highly important to keep a regular balance between fluid and acid within the body to avoid any complications.
Peptide Based Cardiovascular Therapeutics Market: The global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
Peptide Based Metabolic Disorders Therapeutics Market: The global peptide based metabolic disorders therapeutics market, the market is anticipated to show a robust growth rate during the forecasted period of 2017-2022 and expected to reflect a value more than US$ 8 Bn.
Peptide Based Hematological Disorders Therapeutics Market: The global peptide based hematological disorders therapeutics market forecasts that the global peptide based hematological disorders therapeutics market will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
Peptide Based Gastrointestinal Disorders Therapeutics Market: The global peptide based gastrointestinal disorders therapeutics market is set to reflect a double-digit CAGR between 2017 and 2022, to surpass a valuation of US$ 600 Mn. Peptide is a biologically, naturally or artificially constituted form of amino acid monomers. Peptides can be utilized for treating various gastrointestinal disorders that mostly effect parts of the digestive system such as the gastrointestinal tract, large intestine, small intestine, stomach, esophagus, and rectum.
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
E: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
